Yesterday I presented an audioconference on 505(b)(2) candidate selection. A participant posed the following question:
What if our company is developing a drug product (A) and a competitor is also developing a similar product (A’). Can both be approved?
The way this would normally work at FDA is that it would approve the first product [...]
